Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
Filing exhibits
- S-1/A IPO registration
- 3.1 Exhibit 3.1
- 10.2 Exhibit 10.2
- 10.3 Exhibit 10.3
- 10.7 Exhibit 10.7
- 10.10 Exhibit 10.10
- 10.11 Exhibit 10.11(B)
- 10.17 Exhibit 10.17
- 10.18 Exhibit 10.18
- 10.19 Exhibit 10.19A
- 10.19 Exhibit 10.19(B)
- 10.20 Exhibit 10.20
- 10.21 Exhibit 10.21
- 10.22 Exhibit 10.22
- 10.23 Exhibit 10.23
- 10.24 Exhibit 10.24
- 10.25 Exhibit 10.25A
- 10.25 Exhibit 10.25B
- 10.27 Exhibit 10.27
- 23.1 Exhibit 23.1
- 23.2 Exhibit 23.2
AMPH similar filings
Filing view
External links
Exhibit 23.1
Consent of Ernst & Young LLP, Independent Registered Public Accounting Firm
We consent to the reference to our firm under the caption "Experts" and to the use of our report dated March 4, 2005 (except for Notes 1 and 7, as to which the date is April 14, 2005, and Note 14, as to which the date is May 3, 2005) in Amendment No. 1 to the Registration Statement (Form S-1 No. 333-122725) and the related Prospectus of Amphastar Pharmaceuticals, Inc. for the registration of shares of its common stock.
/s/ ERNST & YOUNG LLP
Orange County, California
May 12, 2005